T2 Hyperintense Mass — Differential Diagnosis

T2 hyperintense enhancing masses on breast MRI are typically benign but have important malignant exceptions.

Definition of T2 Hyperintensity

“Lymph node bright” — as bright as a normal axillary or intramammary lymph node on fat-suppressed T2W imaging.

Differential Diagnosis Table

DiagnosisEnhancing?Other Key FeaturesBenign/Malignant
FibroadenomaYesOval/lobulated, circumscribed, homogeneous or dark septationsBenign (most common)
Simple/Complicated cystNo (only thin rim possible)Completely non-enhancing; T2 bright; oval/round circumscribedBenign
Intramammary lymph nodeYesOval, circumscribed, fatty hilum; reniformBenign
PapillomaYesIntraductal; can be T2 hyperintenseBenign (high-risk)
Mucinous carcinomaYesCan be oval/circumscribed; T2 hyperintense due to mucinMalignant
IDC with mucinous featuresYesT2 hyperintense despite malignancy; may have indistinct marginMalignant
IDC (grade 3 / necrosis)YesCentral necrosis bright; rest NOT hyperintense; indistinct/irregularMalignant

Board Pearl

The ≤ 2% cancer risk combination requires ALL FOUR features:

  1. Oval shape
  2. Circumscribed margin
  3. Homogeneous enhancement OR dark internal septations
  4. T2 hyperintense signal

Mucinous carcinoma is the classic malignant mimic — it can be T2 hyperintense and oval, but typically has an indistinct margin or heterogeneous enhancement, breaking the combination.

Mucinous Carcinoma: Key Mimic

Mucinous carcinoma is the most important malignant cause of a T2 hyperintense breast mass:

  • High mucin content → T2 bright, T1 intermediate
  • Can be oval, T2 hyperintense, and slow-enhancing
  • Warning signs: Indistinct or irregular margin; heterogeneous enhancement; older patient; new mass

When the ≤ 2% Rule Applies

If ALL four benign features are met, the mass can typically be managed with:

  • Short-interval follow-up (BI-RADS 3)
  • Or routine screening (BI-RADS 2 if stable on prior MRI)